i.sorensen
Submits third-party assay reports on material purchased directly. Based in Dijon.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
98.29%
n=5
Suppliers covered
5
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041867 | CJC-1295 with DAC | SinoPep | SNP-2607-C3886 | Janoshik | 2026-Q3 | 99.24 | 5.12 | — | Laboratory-retained | 1 | FAIL |
| AX-2026-041553 | GHRP-6 | QSC | QSC-2605-A6715 | VendorInvestigate | 2026-Q2 | 99.93 | 4.95 | 92.4 | Buyer-sourced | 0 | PASS |
| AX-2026-043199 | Exenatide | GL Biochem | GLBI-2509-A7833 | Janoshik | 2026-Q1 | 98.14 | 3.96 | 105.8 | Buyer-sourced | 0 | PASS |
| AX-2025-018509 | Semaglutide | WWB | WWB-2501-K3141 | Nordanalyt | 2025-Q1 | 98.29 | 4.01 | 95.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005075 | SS-31 (Elamipretide) | SSA | SSA-2408-G7111 | Kestrel | 2024-Q3 | 97.75 | 6.41 | 99.9 | Buyer-sourced | 0 | FAIL |
| Supplier | Records | Median purity |
|---|---|---|
| SinoPep | 1 | n<3 |
| QSC | 1 | n<3 |
| GL Biochem | 1 | n<3 |
| WWB | 1 | n<3 |
| SSA | 1 | n<3 |